Related Experiment Video
Updated: May 14, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Self-Explaining Neural Networks for Transparent Parkinson's Disease Screening
Mahmoud E Farfoura1, Ahmad A A Alkhatib1, Tee Connie2
1Cybersecurity Department, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.
Sensors (Basel, Switzerland)
|May 13, 2026
Summary
A new Self-Explaining Neural Network (SENN) accurately screens Parkinson's Disease (PD) using gait analysis. This transparent AI provides clinically relevant explanations, enhancing trust and potential adoption in healthcare.
Area of Science:
- Artificial Intelligence
- Medical Diagnostics
- Biomechanical Analysis
Background:
- Transparent clinical decision-making is crucial for AI in medical diagnosis.
- Post hoc explanation methods for deep learning models lack guaranteed faithfulness to underlying reasoning.
- Parkinson's Disease (PD) diagnosis can benefit from objective gait analysis.
Purpose of the Study:
- To develop a Self-Explaining Neural Network (SENN) for Parkinson's Disease screening.
- To enforce intrinsic interpretability in deep learning models for gait analysis.
- To ensure explanations faithfully reflect the model's diagnostic reasoning.
Main Methods:
- Utilized a residual CNN backbone with stochastic depth regularization.
- Incorporated a 16-concept encoder with diversity and stability constraints.
- Employed temperature-scaled probability calibration for reliable clinical operating points.
- Evaluated on the PhysioNet Gait in Parkinson's Disease dataset using Ground Reaction Force (GRF) data.
Main Results:
- SENN achieved a subject-level ROC-AUC of 0.916, sensitivity of 0.913, and Average Precision of 0.942.
- Interpretability constraints did not significantly reduce discriminative performance compared to baselines.
- Concept-level analysis identified key biomechanical hallmarks of parkinsonian gait.
Conclusions:
- Rigorous intrinsic interpretability and competitive predictive accuracy are achievable simultaneously in deep gait analysis.
- SENN provides clinically grounded, patient-specific explanations for PD screening.
- The developed transparent AI supports potential clinical adoption for diagnostic purposes.
Related Concept Videos
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
